Main competitors
Capi.($) Investor ESG MSCI Fundamentals Financial revisions Global Valuation Visibility Consensus
306B
A
895B
A
587B
BBB
401B
AA
345B
AA
300B
AAA
289B
A
202B
A
184B
AAA
171B
A
154B
BBB
127B
AA
122B
A
111B
AA
107B
A
99.37B
AA
63.66B - - - - - - -
57.28B
AA
54.53B
AA
45.33B
AA
Average 231.19B
AA
Weighted average by Cap.
AA
Other Pharmaceuticals
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW